Literature DB >> 15803023

Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis.

Christine V Whiting1, Paul W Bland, John F Tarlton.   

Abstract

BACKGROUND: n-3 polyunsaturated fatty acids (PUFAs) reduce the severity of chronic inflammatory bowel disease, probably by means of reduction of immune cell activation or enhancement of the epithelial barrier. Using the severe combined immunodeficient (SCID) mouse model of colitis, this study examined the effect of dietary n-3 PUFAs on development of colitis and on immunologic, epithelial, and matrix parameters in the intestines of control and colitic animals.
METHODS: SCID mice were fed n-3-enriched or control diet for 3 weeks before colitis induction by transplantation of CD45RB T cells and maintained on the same diet for 4 to 8 weeks. Phenotype of infiltrating cells, epithelial ZO-1 protein, and mucosal type I collagen were assessed by immunohistology and tissue cytokines by ELISA.
RESULTS: Transplanted n-3-fed animals had significantly reduced pathology scores, colonic tumor necrosis factor-alpha, interleukin-12, and interleukin-1beta compared with animals fed standard diet. Proinflammatory cytokines were reduced despite a similar level of immune cell infiltration by T cells, CD11c cells, and CD11b cells. Neutrophil infiltration was significantly reduced in n-3-fed control and colitic mice, and other myeloid populations were reduced in mice on the n-3 diet. Epithelial ZO-1 expression was increased, and myofibroblast activation significantly decreased in transplanted n-3-fed animals compared with standard diet mice. Submucosal collagen synthesis was enhanced in n-3-fed mice.
CONCLUSIONS: Dietary n-3 PUFAs reduced clinical colitis and colonic immunopathology in this model of colonic inflammation by decreasing proinflammatory cytokine synthesis, reducing myeloid cell recruitment and activation, and enhancing epithelial barrier function and mucosal wound healing mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15803023     DOI: 10.1097/01.mib.0000164016.98913.7c

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  27 in total

Review 1.  The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications.

Authors:  Jason R Goldsmith; R Balfour Sartor
Journal:  J Gastroenterol       Date:  2014-03-21       Impact factor: 7.527

2.  Orally administered emu oil attenuates disease in a mouse model of Crohn's-like colitis.

Authors:  Chloe J Mitchell; Gordon S Howarth; Lauren C Chartier; Debbie Trinder; Ian C Lawrance; Li San Huang; Suzanne Mashtoub
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-09

3.  Protectin DX, a double lipoxygenase product of DHA, inhibits both ROS production in human neutrophils and cyclooxygenase activities.

Authors:  Miao Liu; Tarek Boussetta; Karama Makni-Maalej; Michèle Fay; Fathi Driss; Jamel El-Benna; Michel Lagarde; Michel Guichardant
Journal:  Lipids       Date:  2013-11-20       Impact factor: 1.880

Review 4.  Diet in the pathogenesis and treatment of inflammatory bowel diseases.

Authors:  Dale Lee; Lindsey Albenberg; Charlene Compher; Robert Baldassano; David Piccoli; James D Lewis; Gary D Wu
Journal:  Gastroenterology       Date:  2015-01-15       Impact factor: 22.682

5.  TGFbeta1 expression in colonic mucosa: modulation by dietary lipids.

Authors:  Fiorella Biasi; Cinzia Mascia; Giuseppe Poli
Journal:  Genes Nutr       Date:  2007-09-27       Impact factor: 5.523

Review 6.  Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases.

Authors:  Kyle T Dolan; Eugene B Chang
Journal:  Mol Nutr Food Res       Date:  2016-08-15       Impact factor: 5.914

Review 7.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

8.  Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant.

Authors:  Qiurong Li; Qiang Zhang; Chenyang Wang; Chun Tang; Yanmei Zhang; Ning Li; Jieshou Li
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

9.  Emu oil reduces small intestinal inflammation in the absence of clinical improvement in a rat model of indomethacin-induced enteropathy.

Authors:  Suzanne M Abimosleh; Cuong D Tran; Gordon S Howarth
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-14       Impact factor: 2.629

10.  Effects of increase in fish oil intake on intestinal eicosanoids and inflammation in a mouse model of colitis.

Authors:  Nabil Bosco; Viral Brahmbhatt; Manuel Oliveira; Francois-Pierre Martin; Pia Lichti; Frederic Raymond; Robert Mansourian; Sylviane Metairon; Cecil Pace-Asciak; Viktoria Bastic Schmid; Serge Rezzi; Dirk Haller; Jalil Benyacoub
Journal:  Lipids Health Dis       Date:  2013-05-31       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.